ALPS logo

Alps Group Inc

ALPS
Healthcare|Biotechnology|MY
$0.33
+0.02 (+4.90%)
DCF Value
$0.11
Cash / Share
$0.17

Ownership Breakdown

100.0%
Float
166.4M
Shares Outstanding
166.4M
Float Shares

Major Holders (4)

Combined: 75.6%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Dr. THAM Seng KongIndividual46.36%77,144,380Nov 12, 202513D/G
Lim Kuang SiaIndividual10.32%17,171,873Nov 3, 202513D/G
Crystal Propel SDN. BHD.Corporation9.46%15,750,454Nov 3, 202513D/G
Hock Keat OngIndividual9.46%15,750,454Nov 3, 202513D/G

Insider Trades (9)

Last 4 quarters: 0 acquired · 0 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Lee Hee HangdirectorApr 17, 2026OTHER0——Form 4
Poh Chit LaaSee RemarksMar 18, 2026OTHER0——Form 4
Chua Boon PingdirectorMar 18, 2026OTHER0——Form 4
Chew Yoke LingdirectorMar 18, 2026OTHER0——Form 4
Cheing Lye-PingofficerMar 18, 2026OTHER0——Form 4
Mohamed Suleiman bindirector: Mar 18, 2026OTHER0——Form 4
Manickam RavichandranChief Scientific OfficerMar 18, 2026OTHER0——Form 4
Low Wei SimChief Operating OfficerMar 18, 2026OTHER0——Form 4
Tham Seng Kongdirector, 10 percent owner, officer: Chief Executive OfficerMar 18, 2026OTHER0——Form 4